Correlation Between China SXT and Ravenquest Biomed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China SXT and Ravenquest Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Ravenquest Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China SXT Pharmaceuticals and Ravenquest Biomed, you can compare the effects of market volatilities on China SXT and Ravenquest Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Ravenquest Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Ravenquest Biomed.

Diversification Opportunities for China SXT and Ravenquest Biomed

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between China and Ravenquest is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Ravenquest Biomed in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ravenquest Biomed and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Ravenquest Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ravenquest Biomed has no effect on the direction of China SXT i.e., China SXT and Ravenquest Biomed go up and down completely randomly.

Pair Corralation between China SXT and Ravenquest Biomed

If you would invest  0.00  in Ravenquest Biomed on October 26, 2024 and sell it today you would earn a total of  0.00  from holding Ravenquest Biomed or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.39%
ValuesDaily Returns

China SXT Pharmaceuticals  vs.  Ravenquest Biomed

 Performance 
       Timeline  
China SXT Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Ravenquest Biomed 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ravenquest Biomed has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Ravenquest Biomed is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

China SXT and Ravenquest Biomed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China SXT and Ravenquest Biomed

The main advantage of trading using opposite China SXT and Ravenquest Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Ravenquest Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ravenquest Biomed will offset losses from the drop in Ravenquest Biomed's long position.
The idea behind China SXT Pharmaceuticals and Ravenquest Biomed pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data